Also, the Pulse, based on ATCOR Sphygmocor Xcel technology, being developed by Andon is a step before the Conneqt band. This dual blood pressure device will be a big deal when it gets FDA clearance. The Pulse looks to be an incremental step from the Xcel technology so should have a simpler pathway through FDA. I think CDX have said this 510k application for Pulse is being managed by Andon. Hopefully we get an update soon on when this will be submitted.
Add to My Watchlist
What is My Watchlist?
